Clinical reference Biomarker Directory
Back to directory

Cluster of Differentiation 163

Emerging

CD163 is a macrophage activation marker studied as a complementary test for hyperinflammatory syndromes and liver disease.

Also known as sCD163 soluble CD163 macrophage scavenger receptor
In plain language

CD163 marks a specific type of activated immune cell (macrophages). Its blood-soluble form is being studied as an additional clue, alongside several other markers, to help doctors recognize dangerous immune overactivation conditions and chronic liver disease.

Biomarker & context

CD163 is a scavenger receptor expressed on monocytes and macrophages, particularly anti-inflammatory (M2) macrophages; its soluble form reflects macrophage activation.

What it indicates

Soluble CD163 rises in conditions involving macrophage activation, including hemophagocytic lymphohistiocytosis/macrophage activation syndrome and chronic liver disease, and is being studied as a complementary marker alongside ferritin and the interferon-driven cytokines discussed elsewhere in this set.

Diagnosis & clinical testing

Measured via serum immunoassay; it's used primarily in research settings and select specialized centers rather than as a universally standardized clinical test, reflecting its status as part of an evolving, still-developing diagnostic panel for hyperinflammatory syndromes.

Guiding treatment

Elevated soluble CD163 alongside other markers (ferritin, soluble CD25, cytokine panel) can help distinguish hyperinflammatory syndromes like HLH/MAS from sepsis or other conditions with overlapping presentations, informing the threshold for aggressive immunosuppressive treatment.

Clinical significance

Part of an evolving, still-developing diagnostic panel rather than a universally standardized clinical test at this time.

References
  1. General hematology/hepatology reference literature on soluble CD163 in macrophage activation syndromes and liver disease.